Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study.

Acta diabetologica·2024
Same author

Role of genetic investigation in the diagnosis of short stature in a cohort of Italian children.

Journal of endocrinological investigation·2023
Same author

The clinical management of children with achondroplasia in Italy: results of clinician and parent/caregiver surveys.

Journal of endocrinological investigation·2023
Same author

Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study Italian cohort.

Journal of endocrinological investigation·2020
Same author

X-linked hypophosphatemic rickets: an Italian experts' opinion survey.

Italian journal of pediatrics·2019
Same author

Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: an Italian cohort study.

BMC pediatrics·2019

Related Experiment Video

Updated: Jun 12, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central

B Predieri1, S Luisi, E Casarosa

  • 1Department of Pediatrics, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy. barbara.predieri@unimore.it

Journal of Endocrinological Investigation
|June 10, 2010
PubMed
Summary
This summary is machine-generated.

Allopregnanolone levels in girls with central precocious puberty (CPP) differ based on stimulation type. Gonadal production is suggested, aiding CPP diagnosis.

More Related Videos

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Related Experiment Videos

Last Updated: Jun 12, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

Area of Science:

  • Endocrinology
  • Pediatric Endocrinology
  • Neuroendocrinology

Background:

  • Allopregnanolone, a neuroactive steroid, is implicated in central precocious puberty (CPP).
  • Elevated baseline allopregnanolone levels are observed in girls with CPP.
  • Previous tests suggest both adrenal and ovarian contribution to allopregnanolone production.

Purpose of the Study:

  • To assess allopregnanolone concentrations following GnRH and GnRH agonist analog stimulation in girls with CPP.
  • To elucidate the primary source of allopregnanolone secretion in CPP.

Main Methods:

  • Evaluation of gonadotropins and steroid hormones in 15 girls with CPP.
  • Administration of GnRH and triptorelin (GnRH agonist analog) stimulation tests.
  • Measurement of allopregnanolone, LH, FSH, estradiol, and DHEAS levels post-stimulation.

Main Results:

  • GnRH stimulation led to significant increases in LH, FSH, and allopregnanolone.
  • Triptorelin administration resulted in significant increases in LH, FSH, estradiol, and DHEAS.
  • Triptorelin administration caused a significant decrease in allopregnanolone levels.

Conclusions:

  • Differential allopregnanolone response to GnRH and its agonist analog suggests varying mechanisms of action.
  • Data indicate a predominant gonadal source for allopregnanolone in CPP subjects.
  • Allopregnanolone measurement may be a valuable diagnostic tool for CPP.